These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children. Brigotti M; He X; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Tazzari PL; Ricci F; Patfield SA; Testa S; Paglialonga F; Picicco D; Caprioli A; Scavia G; Morabito S; Ardissino G Thromb Haemost; 2020 Jan; 120(1):107-120. PubMed ID: 31858520 [TBL] [Abstract][Full Text] [Related]
12. Detection and characterization of circulating microvesicles containing Shiga toxin type 2 in a rat model of Hemolytic Uremic Syndrome. Sacerdoti F; Gomez FD; Jancic C; Lombardo T; Pascuale CA; Moretton MA; Chiappetta DA; Ibarra C; Amaral MM Toxicon; 2023 Dec; 236():107349. PubMed ID: 37979924 [TBL] [Abstract][Full Text] [Related]
13. Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS). Exeni RA; Fernandez-Brando RJ; Santiago AP; Fiorentino GA; Exeni AM; Ramos MV; Palermo MS Pediatr Nephrol; 2018 Nov; 33(11):2057-2071. PubMed ID: 29372302 [TBL] [Abstract][Full Text] [Related]
14. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543 [TBL] [Abstract][Full Text] [Related]
16. Divergent roles of haptoglobin and hemopexin deficiency for disease progression of Shiga-toxin-induced hemolytic-uremic syndrome in mice. Pirschel W; Mestekemper AN; Wissuwa B; Krieg N; Kröller S; Daniel C; Gunzer F; Tolosano E; Bauer M; Amann K; Heinemann SH; Coldewey SM Kidney Int; 2022 Jun; 101(6):1171-1185. PubMed ID: 35031328 [TBL] [Abstract][Full Text] [Related]
17. The Fatal Role of Enterohaemorrhagic Escherichia coli Shiga Toxin-associated Extracellular Vesicles in Host Cells. Lee KS; Park JY; Jeong YJ; Lee MS J Microbiol; 2023 Aug; 61(8):715-727. PubMed ID: 37665555 [TBL] [Abstract][Full Text] [Related]
18. Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions. Karpman D; Ståhl AL; Arvidsson I; Johansson K; Loos S; Tati R; Békássy Z; Kristoffersson AC; Mossberg M; Kahn R Adv Exp Med Biol; 2015; 865():19-42. PubMed ID: 26306441 [TBL] [Abstract][Full Text] [Related]
19. Shiga toxin triggers endothelial and podocyte injury: the role of complement activation. Zoja C; Buelli S; Morigi M Pediatr Nephrol; 2019 Mar; 34(3):379-388. PubMed ID: 29214442 [TBL] [Abstract][Full Text] [Related]